These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 2986274)
1. Prevention of leukocyte migration inhibitory factor activity by glucagon. Pereţianu D; Deleanu A; Lotreanu V; Mogoş A; Beşliu C; Tănase D Med Interne; 1985; 23(1):63-6. PubMed ID: 2986274 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients. Crivii SM; Crişan M; Crişan M Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694 [TBL] [Abstract][Full Text] [Related]
3. Use of benzoyl-L-phenylalanyl-L-valyl-L-arginine (3H) methyl ester as a sensitive and selective substrate for the human lymphokine, leukocyte migration inhibitory factor (LIF). Bendtzen K; Rocklin RE J Immunol; 1980 Oct; 125(4):1775-81. PubMed ID: 6251137 [TBL] [Abstract][Full Text] [Related]
4. [Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels in cancer tissue, plasma and urine of esophageal cancer patients]. Zhao CY Zhonghua Zhong Liu Za Zhi; 1985 May; 7(3):175-7. PubMed ID: 2990838 [No Abstract] [Full Text] [Related]
5. Mechanism of the impairment of the glucagon-stimulated phosphoenolpyruvate carboxykinase gene expression by interleukin-6 in rat hepatocytes: inhibition of the increase in cyclic 3',5' adenosine monophosphate and the downstream cyclic 3',5' adenosine monophosphate action. Christ B; Nath A; Jungermann K Hepatology; 1997 Jul; 26(1):73-80. PubMed ID: 9214454 [TBL] [Abstract][Full Text] [Related]
7. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF. Bendtzen K J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804 [TBL] [Abstract][Full Text] [Related]
8. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients]. Puppo F; Corsini G; Mangini P; Armani U; Piana A Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916 [No Abstract] [Full Text] [Related]
9. The effect of corticosteroids and other antineoplastic agents on the generation of leukocyte migration inhibition factor. Li J; Yousefi S; Sterling M; Carandang G; Vaziri N; Pahl M; Cesario T J Clin Lab Immunol; 1987 Jan; 22(1):13-7. PubMed ID: 3104595 [TBL] [Abstract][Full Text] [Related]
10. [The functional characteristics of the interaction of lymphokine-producing lymphocytes with granulocytes of the peripheral blood and skin in dermatosis patients]. Kozin VM; Adamenko GP; Bogdanovich LI; Iakirevich EV Vestn Dermatol Venerol; 1990; (3):29-32. PubMed ID: 2195796 [TBL] [Abstract][Full Text] [Related]
11. [Studies on the pathogenic mechanism of hypersensitivity to antibacterial agents--correlations of leucocyte migration activating factor and leucocyte migration inhibitory factor with interleukin-2 and interferon-gamma]. Uno K Arerugi; 1993 May; 42(5):656-64. PubMed ID: 8323465 [TBL] [Abstract][Full Text] [Related]
12. Effect of cAMP and related compounds on newt epidermal cell migration both in vivo and in vitro. Dunlap MK; Donaldson DJ J Exp Zool; 1980 Apr; 212(1):13-9. PubMed ID: 6251154 [TBL] [Abstract][Full Text] [Related]
13. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF). Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762 [TBL] [Abstract][Full Text] [Related]
14. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood. Skopińska E; Lukasik R Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792 [TBL] [Abstract][Full Text] [Related]
16. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions. Pettersson T; Welin MG; Weber TH J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387 [TBL] [Abstract][Full Text] [Related]
17. "In vitro" and "in vivo" leukocyte migration inhibitory factor production in acute infectious mononucleosis patients. Bertotto A; Gentili F; Stagni G; Zucchetti Z; Vaccaro R Boll Ist Sieroter Milan; 1983 Jul; 62(3):281-6. PubMed ID: 6357231 [TBL] [Abstract][Full Text] [Related]
18. [Studies on the pathogenic mechanism of beta-lactam hypersensitivity by the detection of leucocyte migration activating factor and leucocyte migration inhibitory factor]. Uno K Arerugi; 1990 Dec; 39(12):1605-11. PubMed ID: 2096806 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous production of an inhibitor in vitro lymphocyte migration by lymphocytes from patients with Hodgkin's disease and mycosis fungoides. Skopińska-Rónzewska E; Zółtowska A; Dziewulska-Bokiniec A Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):57-62. PubMed ID: 6756337 [No Abstract] [Full Text] [Related]
20. Monocyte regulation of lymphokine production in cancer patients. Kowalczyk D; Ruggiero I; Zembala M J Clin Lab Immunol; 1986 Jan; 19(1):37-41. PubMed ID: 3517344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]